Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/ computerized tomography (FDG PET/CT)

被引：0

作者：

B. Do

C. Mari

S. Biswal

J. Kalinyak

A. Quon

S. S. Gambhir

机构：

[1] Stanford University Medical Center,Nuclear Medicine Division, Department of Radiology and Molecular Imaging Program at Stanford (MIPS)

[2] San Francisco Veteran Affairs,Nuclear Medicine Division, Department of Radiology

[3] UCSF,Nuclear Medicine Program, Department of Radiology and Center for Molecular and Functional Imaging (CMFI)

[4] University of California,San Francisco (UCSF), Nuclear Medicine, Radiology Department

来源：

Annals of Nuclear Medicine | 2006年 / 20卷

关键词：

FDG PET/CT; aseptic thrombosis; deep vanous thrombosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We describe a patient with a history of recurrent squamous cell carcinoma of the tongue and abnormal FDG uptake in the left arm during a re-staging FDG PET/CT. After revision of the patient’s clinical history, tests and physical exam, the abnormal FDG uptake was found to correspond to an extensive aseptic deep venous thrombosis of the upper extremity.

引用

页码：151 / 155

页数：4

共 50 条

[21] Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis
Bassetti, Matteo
Merelli, Maria
Di Gregorio, Fernando
Della Siega, Paola
Screm, Maria
Scarparo, Claudio
Righi, Elda
SKELETAL RADIOLOGY, 2017, 46 (06) : 777 - 783
[22] Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
Saila Kauhanen
Camilla Schalin-Jäntti
Endocrine, 2012, 42 : 461 - 463
[23] Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer
Kosuda, S
Kison, PV
Greenough, R
Grossman, HB
Wahl, RL
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (06) : 615 - 620
[24] Fluorine-18 fluorodeoxyglucose positron emission tomography for the detection of recurrent gynecologic cancer.
Khan, N
Oriuchi, N
Kanuma, T
Higuchi, T
Miyakubo, M
Endo, K
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S329 - S329
[25] Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
Kauhanen, Saila
Schalin-Jantti, Camilla
ENDOCRINE, 2012, 42 (03) : 461 - 463
[26] The value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with medullary thyroid cancer
Katja Brandt-Mainz
Stefan P. Müller
Rainer Görges
Bernhard Saller
Andreas Bockisch
European Journal of Nuclear Medicine, 2000, 27 : 490 - 496
[27] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer:: results of a multicentre study
Grünwald, F
Kälicke, T
Feine, U
Lietzenmayer, R
Scheidhauer, K
Dietlein, M
Schober, O
Lerch, H
Brandt-Mainz, K
Burchert, W
Hiltermann, G
Cremerius, U
Biersack, HJ
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (12) : 1547 - 1552
[28] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
Boerner, AR
Weckesser, M
Herzog, H
Schmitz, T
Audretsch, W
Nitz, U
Bender, HG
Mueller-Gaertner, HW
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (03) : 226 - 230
[29] CLINICAL SIGNIFICANCE OF FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR RECURRENT COLORECTAL CANCER
Ishikawa, H.
Watanabe, A.
Ohyama, T.
Mukogawa, T.
Inoue, T.
Kinoshita, S.
Kawai, N.
Nakagawa, K.
Emoto, K.
Ogawa, S.
GUT, 2009, 58 : A86 - A86
[30] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study
Frank Grünwald
Thomas Kälicke
Ulrich Feine
Roland Lietzenmayer
Klemens Scheidhauer
Markus Dietlein
Otmar Schober
Hartmut Lerch
Katja Brandt-Mainz
Wolfgang Burchert
Gerhard Hiltermann
Uwe Cremerius
Hans-Jürgen Biersack
European Journal of Nuclear Medicine, 1999, 26 : 1547 - 1552

← 1 2 3 4 5 →